What’s the current market cap for Alexandria Real Estate Equities stock?

Alexandria Real Estate Equities (ARE) has a market cap of $8.9bn as of June 06, 2026.

What is the P/E ratio for Alexandria Real Estate Equities stock?

The price to earnings (P/E) ratio for Alexandria Real Estate Equities (ARE) stock is 0 as of June 06, 2026.

Does Alexandria Real Estate Equities stock pay dividends?

Yes, the Alexandria Real Estate Equities (ARE) stock pays dividends to shareholders. As of June 06, 2026, the dividend rate is $4.08 and the yield is 5.62%. Alexandria Real Estate Equities has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Alexandria Real Estate Equities dividend payment date?

The next Alexandria Real Estate Equities (ARE) dividend payment is scheduled for July 15, 2026.

What is the beta indicator for Alexandria Real Estate Equities?

Alexandria Real Estate Equities (ARE) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy Alexandria Real Estate Equities stock | $ARE Share Price

13:30

15:10

16:45

18:25

20:00

About Alexandria Real Estate Equities

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Ticker

$ARE

Sector

Real Estate

Primary listing

NYSE

Employees

514

Headquarters

Pasadena, United States

Website

www.are.com

ARE Metrics

BasicAdvanced

$8.9bn

-$6.27

1.14

$4.08

5.62%

What the Analysts think about ARE

Analyst ratings (Buy, Hold, Sell) for Alexandria Real Estate Equities stock.

Bulls say / Bears say

Q1 2026 diluted adjusted FFO per share came in at $1.73 and management reaffirmed the full-year 2026 FFO midpoint at $6.40, demonstrating solid cash flow generation despite industry headwinds (NASDAQ)

General and administrative expenses were reduced by 18% from the average level reported in 2024 quarters, with G&A accounting for 6.0% of NOI—roughly half the S&P 500 REIT average—showing greater operational efficiency (NASDAQ)

Under its December 2025 authorization, the board can repurchase up to $500 million of common stock by December 31, 2026, reflecting management's confidence in the company's valuation and its commitment to returning value to shareholders (NASDAQ)

Average occupancy dropped to 88.9% in Q1 2026 from 94.0% in Q1 2025, a fall of 510 basis points, highlighting ongoing tenant downsizing and leasing headwinds in core life science markets (NASDAQ)

Same property net operating income decreased by 11.9% year-over-year in Q1 2026, indicating continued pressure on rental rates and challenging leasing conditions in the life science sector (NASDAQ)

Leverage is high, with net debt and preferred stock to Adjusted EBITDA at 6.8x annualized in Q1 2026 and expected to remain elevated at 5.6x–6.2x in Q4 2026 (up from 3.6x–4.1x), which could strain financial flexibility and raise interest coverage risk (NASDAQ)

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.

ARE Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

ARE Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ARE

Capital at risk

Market closed

Upcoming events

Bulls say / Bears say

Average occupancy dropped to 88.9% in Q1 2026 from 94.0% in Q1 2025, a fall of 510 basis points, highlighting ongoing tenant downsizing and leasing headwinds in core life science markets (NASDAQ)

Same property net operating income decreased by 11.9% year-over-year in Q1 2026, indicating continued pressure on rental rates and challenging leasing conditions in the life science sector (NASDAQ)

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.